A Basket Trial of an ERK1/2 Inhibitor (LY3214996) in Combination With Abemaciclib.

Clinical trial NCT04534283 · TERMINATED

Trial details

NCT number: NCT04534283
Sponsor: Anita Turk
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Cancer Cancer Metastatic BRAF V600E MEK1 Gene Mutation MEK2 Gene Mutation ERK Mutation RAF1 Gene Mutation

Start date: 2020-10-05
Primary completion: 2023-08-07
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.